Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (1-10 of 437) with videos related to

Pageof 44
Sort By:
Rheumatology (Oxford, England)|September 6, 2023
The use of JAK inhibitors and the impact of comorbiditiesFabiola Atzeni, Alessandra Alciati
Rheumatology (Oxford, England)|January 24, 2023
A self-tracking tool for detecting chronic widespread pain in axial spondyloarthritisFabiola Atzeni, Alessandra Alciati
Polish Archives of Internal Medicine|February 27, 2025
Cardiovascular risk and psoriatic arthritisFabiola Atzeni, Alessandra Alciati
The Lancet. Rheumatology|June 14, 2025
Dual JAK and ROCK inhibition and comorbidities in rheumatoid arthritisFabiola Atzeni, James Galloway
Journal of Clinical Medicine|April 28, 2023
Cardiovascular Risk in Systemic Inflammatory ArthritisFabiola Atzeni, Alessandra Alciati
Expert Review of Clinical Immunology|March 7, 2022
JAK inhibitors: special issue forewordJames Galloway, Fabiola Atzeni
The Israel Medical Association Journal : IMAJ|June 5, 2015
Autoimmune hepatitis and allergic reactions during anti-TNFα treatmentFabiola Atzeni, Piercarlo Sarzi-Puttini
Nature Reviews. Rheumatology|March 7, 2012
Rheumatoid arthritis: Why wait? Explaining delays in seeking therapy for early arthritisFabiola Atzeni, Piercarlo Sarzi-Puttini
Expert Review of Clinical Immunology|March 7, 2012
Twelve years' experience with etanercept in the treatment of rheumatoid arthritis: how it has changed clinical practiceFabiola Atzeni, Piercarlo Sarzi-Puttini
The Israel Medical Association Journal : IMAJ|December 3, 2014
New biological treatments for psoriatic arthritisPiercarlo Sarzi-Puttini, Fabiola Atzeni
Pageof 44

Showing results (1-10 of 437) with videos related to

Sort By:
Pageof 44
Rheumatology (Oxford, England)|September 6, 2023
The use of JAK inhibitors and the impact of comorbiditiesFabiola Atzeni, Alessandra Alciati
Rheumatology (Oxford, England)|January 24, 2023
A self-tracking tool for detecting chronic widespread pain in axial spondyloarthritisFabiola Atzeni, Alessandra Alciati
Polish Archives of Internal Medicine|February 27, 2025
Cardiovascular risk and psoriatic arthritisFabiola Atzeni, Alessandra Alciati
The Lancet. Rheumatology|June 14, 2025
Dual JAK and ROCK inhibition and comorbidities in rheumatoid arthritisFabiola Atzeni, James Galloway
Journal of Clinical Medicine|April 28, 2023
Cardiovascular Risk in Systemic Inflammatory ArthritisFabiola Atzeni, Alessandra Alciati
Expert Review of Clinical Immunology|March 7, 2022
JAK inhibitors: special issue forewordJames Galloway, Fabiola Atzeni
The Israel Medical Association Journal : IMAJ|June 5, 2015
Autoimmune hepatitis and allergic reactions during anti-TNFα treatmentFabiola Atzeni, Piercarlo Sarzi-Puttini
Nature Reviews. Rheumatology|March 7, 2012
Rheumatoid arthritis: Why wait? Explaining delays in seeking therapy for early arthritisFabiola Atzeni, Piercarlo Sarzi-Puttini
Expert Review of Clinical Immunology|March 7, 2012
Twelve years' experience with etanercept in the treatment of rheumatoid arthritis: how it has changed clinical practiceFabiola Atzeni, Piercarlo Sarzi-Puttini
The Israel Medical Association Journal : IMAJ|December 3, 2014
New biological treatments for psoriatic arthritisPiercarlo Sarzi-Puttini, Fabiola Atzeni
Pageof 44